SandeepMoothedath Subrahmanian
PhD
Location
Hershey, PA, USA
Current Organization
Pennsylvania State University College of Medicine
Biography
Dr. Sandeep Moothedath Subrahmanian, PhD, is a postdoctoral scholar in the laboratory of Dr. Michael Dennis in the Department of Cellular & Molecular Physiology at Penn State College of Medicine. He earned his master’s degree in biochemistry from the University of Calicut, Calicut, India, in 2010 and completed his doctorate in biochemistry in 2019 at the University of Mysore, Mysuru, India. During his doctoral studies, Dr. Subrahmanian focused on the impact of maternal diabetes on proteoglycans in the fetal brain and the long-term implications of in-utero conditions on offspring development.
Following his graduate training, he completed postdoctoral fellowships at the Oklahoma Medical Research Foundation and in the Department of Orthopedics at Penn State. His prior postdoctoral research was focused on TGFß and PEDF growth factors signaling in cellular reprogramming. In 2022, Dr. Subrahmanian joined Dr. Dennis’ lab, where he collaborates closely with his co-mentors Dr. Barber and Dr. Sundstrom from Ophthalmology. Dr. Subrahmanian’s current research at Penn State is dedicated to investigating signaling events contributing to retinal oxidative stress and inflammation in age-related macular degeneration. Dr. Subrahmanian previously received a pilot grant from the Comprehensive Health Studies Program at Penn State.
News Featuring This Grantee
Newsletters
Macular Degeneration Research News: Spring 2026
In this issue: Switching Off a Harmful Protein Could Help Protect Vision, Doug Finds Hope Amid Vision Loss, How Ongoing Treatment Helps Slow Geographic Atrophy, and more!
Research News
How Targeting a Molecular 'Switch' Could Inspire New Macular Degeneration Treatments
A researcher funded by BrightFocus’ Macular Degeneration Research is zeroing in on a protein that damages eye cells in the early stages of dry age-related macular degeneration, offering insights that could lead to new treatments.